Oxidative stress and protein glycation in primary hypothyroidism. Male/female difference

  • Nivedita Nanda
  • Zachariah BobbyEmail author
  • Abdoul Hamide


Oxidative stress (OS) has recently been documented in hypothyroidism, a disease more prevalent in women. In general, OS is reported to be more prevalent in males. However, the effect of gender on OS and protein glycation in hypothyroidism has not been addressed. Blood samples from 37 recently diagnosed primary hypothyroid patients were collected before initiation of thyroxine therapy. Serum glucose, thyroid and lipid profiles were estimated. Glutathione (GSH), malondialdehyde (MDA), protein carbonylation (PCO) and fructosamine levels were analysed. GSH was found to be lower, whereas MDA, fructosamine and PCO levels were higher in male than in female patients. Level of MDA was significantly correlated with fructosamine, protein carbonyls, cholesterol, low-density and high-density lipoprotein cholesterol, triglyceride and GSH in hypothyroid patients. We found OS to be more prevalent in male hypothyroid patients. The positive association of MDA with fructosamine indicates that enhanced lipid peroxidation could be a plausible contributor for accelerated glycation of protein. Considering the negative influence of OS on health, extra attention should be paid to male hypothyroid patients in spite of the low prevalence of this disease in them.


Hypothyroidism Fructosamine Oxidative stress Protein glycation Male/female difference 


  1. 1.
    Yen PM (2001) Physiological and molecular basis of thyroid hormone action. Physiol Rev 81:1097–1142PubMedGoogle Scholar
  2. 2.
    Bianchi G, Solaroli E, Zaccheroni V et al (1999) Oxidative stress and anti-oxidant metabolites in patients with hyperthyroidism: effect of treatment. Horm Metab Res 31:620–624PubMedCrossRefGoogle Scholar
  3. 3.
    Sarandol E, Tas S, Dirican M, Serdar Z (2005) Oxidative stress and serum paraoxonase activity in experimental hypothyroidism: effect of vitamin E supplementation. Cell Biochem Funct 23:1–8PubMedCrossRefGoogle Scholar
  4. 4.
    Yilmaz S, Ozan S, Benzer F, Canatan H (2003) Oxidative damage and antioxidant enzyme activities in experimental hypothyroidism. Cell Biochem Funct 21:325–330PubMedCrossRefGoogle Scholar
  5. 5.
    Baskol G, Atmaca H, Tanriverdi F et al (2007) Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment. Exp Clin Endocrinol Diabetes 115:522–526PubMedGoogle Scholar
  6. 6.
    Tenorio-Velázquez VM, Barrera D, Franco M et al (2005) Hypothyroidism attenuates protein tyrosine nitration, oxidative stress and renal damage induced by ischemia and reperfusion: effect unrelated to antioxidant enzymes activities. BMC Nephrol 6:12PubMedCrossRefGoogle Scholar
  7. 7.
    Sener G, Sehirli O, Velioglu-Ogunc A et al (2006) Propylthiouracil (PTU)-induced hypothyroidism alleviates burn-induced multiple organ injury. Burns 32:728–736PubMedCrossRefGoogle Scholar
  8. 8.
    Rastogi L, Godbole MM, Ray M et al (2006) Reduction in oxidative stress and cell death explains hypothyroidism induced neuroprotection subsequent to ischemia/reperfusion insult. Exp Neurol 200:290–300PubMedCrossRefGoogle Scholar
  9. 9.
    Nivedita N, Zachariah B, Abdoul H et al (2007) Association between oxidative stress and coronary lipid risk factors in hypothyroid women is independent of body mass index. Metabolism 56:1350–1355CrossRefGoogle Scholar
  10. 10.
    Taddei S, Caraccio N, Virdis A et al (2006) Low-grade systemic inflammation causes endothelial dysfunction in patients with Hashimoto’s thyroiditis. J Clin Endocrinol Metab 91:5076–5082PubMedCrossRefGoogle Scholar
  11. 11.
    Taddei S, Caraccio N, Virdis A et al (2003) Impaired endothelium dependent vasodilation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. J Clin Endocrinol Metab 88:3731–3737PubMedCrossRefGoogle Scholar
  12. 12.
    Reusch CE, Gerber B, Boretti FS (2002) Serum fructosamine concentrations in dogs with hypothyroidism. Vet Res Commun 26:531–536PubMedCrossRefGoogle Scholar
  13. 13.
    Sako Y, Umeda F, Hashimoto T et al (1989) Serum fructosamine in assessment of diabetic control and relation to thyroid function. Horm Metab Res 21:669–672PubMedGoogle Scholar
  14. 14.
    Cirillo R, Balzano S, Cossu E et al (1988) The effect of altered thyroid function on serum fructosamine concentrations. Clin Biochem 21:179–181PubMedCrossRefGoogle Scholar
  15. 15.
    Hara H, Ban Y, Taniyama M et al (1990) The significance of serum fructosamine measurement in patients with thyroid diseases. Nippon Naibunpi Gakkai Zasshi 66:1075–1084PubMedGoogle Scholar
  16. 16.
    Cohen MP, Shea E, Chen S, Shearman CW (2003) Glycated albumin increases oxidative stress, activates NF-kB and extracellular signal-regulated kinase (ERK), and stimulates ERK-dependent transforming growth factor-b1 production in macrophage RAW cells. J Lab Clin Med 141:242–249PubMedCrossRefGoogle Scholar
  17. 17.
    Li N, Karin M (1999) Is NF-kB the sensor of oxidative stress? FASEB J 13:1137–1143PubMedGoogle Scholar
  18. 18.
    Sutken E, Inal M, Ozdemir F (2006) Effects of vitamin E and gemfibrozil on lipid profiles, lipid peroxidation and antioxidant status in the elderly and young hyperlipidemic subjects. Saudi Med J 27:453–459PubMedGoogle Scholar
  19. 19.
    Buettner GR (1993) The packing order of free radicals and antioxidants: lipid peroxidation, α-tocopherol and ascorbate. Arch Biochem Biophys 300:535–543PubMedCrossRefGoogle Scholar
  20. 20.
    Porter NA (1984) Chemistry of lipid peroxidation. Methods Enzymol 105:273–282PubMedCrossRefGoogle Scholar
  21. 21.
    Ren J (2007) Influence of gender on oxidative stress, lipid peroxidation, protein damage and apoptosis in hearts and brains from spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 34:432PubMedCrossRefGoogle Scholar
  22. 22.
    Bayr H, Marion DW, Puccio AM et al (2004) Marked gender effect on lipid peroxidation after severe traumatic brain injury in adult patients. J Neurotrauma 21:1–8CrossRefGoogle Scholar
  23. 23.
    Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499–502PubMedGoogle Scholar
  24. 24.
    Fairbanks VF, Klee GG (1999) Biochemical aspects of hematology. In: Burtis CA, Ashwood ER (eds) Tietz textbook of clinical chemistry, 3rd Edn. Saunders Publications, Washington, p 1653Google Scholar
  25. 25.
    Wendel A (1981) Glutathione peroxidase. Methods Enzymol 105:325–333CrossRefGoogle Scholar
  26. 26.
    Habig WM (1947) Glutathione S transferase. J Biol Chem 249:7130–7139Google Scholar
  27. 27.
    Aebi H (1984) Catalase in vitro. Methods Enzymol 105:121–126PubMedCrossRefGoogle Scholar
  28. 28.
    Reznick AZ, Packer L (1994) Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol 233:357–363PubMedCrossRefGoogle Scholar
  29. 29.
    Satoh K (1978) Serum lipid peroxide in cardiovascular disease, determined by a new colorimetric method. Clin Chim Acta 90:37–43PubMedCrossRefGoogle Scholar
  30. 30.
    Sacks DB (2006) Carbohydrates. In: Burtis CA, Ashwood ER (eds) Tietz textbook of clinical chemistry, 4th Edn. Saunders Publications, Washington, p 884Google Scholar
  31. 31.
    Lapolla A, Traldi P, Fedele D (2005) Importance of measuring products of non enzymatic glycation of proteins. Clin Biochem 38:103–115PubMedCrossRefGoogle Scholar
  32. 32.
    Jain SK, Palmer M (1997) The effect of oxygen radicals metabolites and vitamin E on glycosylation of proteins. Free Radic Biol Med 22:593–596PubMedCrossRefGoogle Scholar
  33. 33.
    Huby R, Harding JJ (1998) Non enzymic glycosylation (glycation) of lens proteins by galactose and protection by aspirin and reduced glutathione. Exp Eye Res 47:53–59CrossRefGoogle Scholar
  34. 34.
    Sathiyapriya V, Bobby Z, Vinod Kumar S et al (2006) Evidence for the role of lipid peroxides on glycation of hemoglobin and plasma proteins in non-diabetic asthma patients. Clin Chim Acta 366:299–303PubMedCrossRefGoogle Scholar
  35. 35.
    Sabter J, Quereda C, Herra I et al (1991) Nonenzymatic glycosylation of hemoglobin and total plasma proteins in end stage renal disease. Am J Nephrol 11:37–43Google Scholar
  36. 36.
    Baynes JW (1991) Role of oxidative stress in development of complications in diabetes. Diabetes 40:405–412PubMedCrossRefGoogle Scholar
  37. 37.
    Radar DJ, Hobbs HH (2005) Disorders of lipoprotein metabolism. In: Kasper DL, Braunwald E, Fauci AS et al (eds) Harrison’s principles of internal medicine, Vol II, 16th Edn. McGraw-Hill, New York, p 2294Google Scholar
  38. 38.
    Sarkar M, Varshney R, Chopra M et al (2005) Flow cytometric analysis of reactive oxygen species in peripheral blood mononuclear cells of patients with thyroid dysfunction. Cytometry Part B (Clin Cytometry) 70:20–23Google Scholar
  39. 39.
    Ohara Y, Peterson TE, Harrison DG (1993) Hypercholesterolemia increases endothelial superoxide anion production. J Clin Invest 91:2546–2551PubMedCrossRefGoogle Scholar
  40. 40.
    Dalle-Donne I, Rossi R, Giustarini D et al (2003) Protein carbonyl groups as biomarkers of oxidative stress. Clin Chim Acta 329:23–38PubMedCrossRefGoogle Scholar
  41. 41.
    Strachan MWJ, Walker BR (2006) Endocrine disease. In: Boon NA, College NR, Walker BR (eds) Davidson’s principles and practice of medicine, 20th Edn. Churchill-Livingstone-Elsevier, Edinburgh, p 750Google Scholar
  42. 42.
    Radar DJ, Hobbs HH (2005) Disorders of lipoprotein metabolism. In: Kasper D, Braunwald E, Fauci A et al (eds) Harrison’s principles of internal medicine, Vol II, 16th Edn. McGraw-Hill, New York, p 2294Google Scholar
  43. 43.
    Dardano A, Ghiadoni L, Plantinga Y et al (2006) Recombinant human TSH reduces endothelial-dependent vasodilation in patients monitored for differentiated thyroid carcinoma. J Clin Endocrinol Metab 91:4175–4178PubMedCrossRefGoogle Scholar
  44. 44.
    Radar DJ, Hobbs HH (2005) Disorders of lipoprotein metabolism. In: Kasper D, Braunwald E, Fauci A et al (eds) Harrison’s principles of internal medicine, Vol II, 16th Edn. McGraw-Hill, New York, pp 2110–2112Google Scholar
  45. 45.
    Mishkel MA, Crowher SM (1977) Hypothyroidism an important cause of reversible hyperlipidemia. Clin Chim Acta 74:139–151PubMedCrossRefGoogle Scholar
  46. 46.
    O’Brien T, Dinneen SF, O’Brien PC, Palumbo PJ (1993) Hyperlipidemia in patients with primary and secondary hypothyroidism. Mayo Clin Proc 68:860–866PubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2008

Authors and Affiliations

  • Nivedita Nanda
    • 1
  • Zachariah Bobby
    • 1
    Email author
  • Abdoul Hamide
    • 2
  1. 1.Department of BiochemistryJawaharlal Institute of Postgraduate Medical Education and Research (JIPMER)PondicherryIndia
  2. 2.Department of MedicineJawaharlal Institute of Postgraduate Medical Education and Research (JIPMER)PondicherryIndia

Personalised recommendations